Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
Parkinson’s disease (PD), the second most common neurodegenerative disorder after Alzheimer’s disease, is a clinically heterogeneous disorder, with obscure etiology and no disease-modifying therapy to date. Currently, there is no available biomarker for PD endophenotypes or disease progression. Accu...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2020-10-01
|
| coleção: | Brain Sciences |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2076-3425/10/10/713 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|